About Singulex
Singulex is a company based in Alameda (United States) founded in 1997.. Singulex has raised $140.94 million across 16 funding rounds from investors including SVB, Grifols and HHS. The company has 236 employees as of December 31, 2017. Singulex offers products and services including Sgx Clarity System. Singulex operates in a competitive market with competitors including Metabolon, Maze Therapeutics, Seer, Alector and NanoCellect Biomedical, among others.
- Headquarter Alameda, United States
- Employees 236 as on 31 Dec, 2017
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$140.94 M (USD)
in 16 rounds
-
Latest Funding Round
$50 M (USD), Debt – Conventional
Apr 17, 2017
-
Investors
SVB
& 10 more
-
Employee Count
236
as on Dec 31, 2017
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Singulex
Singulex offers a comprehensive portfolio of products and services, including Sgx Clarity System. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Ultra-sensitive platform for detecting low-abundance biomarkers in healthcare
Funding Insights of Singulex
Singulex has successfully raised a total of $140.94M across 16 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $50 million completed in April 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 16
- Last Round Debt – Conventional — $50.0M
-
First Round
First Round
(23 Oct 2002)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2017 | Amount | Debt – Conventional - Singulex | Valuation |
investors |
|
| May, 2016 | Amount | Series G - Singulex | Valuation |
investors |
|
| Sep, 2013 | Amount | Debt – Conventional - Singulex | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Singulex
Singulex has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Grifols and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Venture debt firm focused on the life sciences sector
|
Founded Year | Domain | Location | |
|
Health-focused venture capital investments are made in US sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Singulex
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Singulex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Singulex Comparisons
Competitors of Singulex
Singulex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Metabolon, Maze Therapeutics, Seer, Alector and NanoCellect Biomedical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| domain | founded_year | HQ Location |
Genetic biomarkers are developed for neurological, metabolic, and renal diseases.
|
|
| domain | founded_year | HQ Location |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| domain | founded_year | HQ Location |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
|
|
| domain | founded_year | HQ Location |
Develops flow cytometry and cell sorting technology
|
|
| domain | founded_year | HQ Location |
Single-cell data is analyzed via AI for biomarker discovery.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Singulex
Frequently Asked Questions about Singulex
When was Singulex founded?
Singulex was founded in 1997 and raised its 1st funding round 5 years after it was founded.
Where is Singulex located?
Singulex is headquartered in Alameda, United States. It is registered at Alameda, California, United States.
Who is the current CEO of Singulex?
Guido Baechler is the current CEO of Singulex.
Is Singulex a funded company?
Singulex is a funded company, having raised a total of $140.94M across 16 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $40M, raised on Oct 23, 2002.
How many employees does Singulex have?
As of Dec 31, 2017, the latest employee count at Singulex is 236.
What does Singulex do?
Singulex was founded in 1997 in Alameda, United States, and operates in the biotechnology sector focused on cardiodiagnostics. Single-molecule counting instruments and biomarker research are developed and commercialized for cardiovascular monitoring. Immunoassay solutions, lab testing services, and the Clarity System for automated in vitro analysis are provided to support disease treatment, health management, and therapeutic development.
Who are the top competitors of Singulex?
Singulex's top competitors include Alector, Maze Therapeutics and Metabolon.
What products or services does Singulex offer?
Singulex offers Sgx Clarity System.
Who are Singulex's investors?
Singulex has 11 investors. Key investors include SVB, Grifols, HHS, Orbimed, and Western Alliance Bank.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.